• 1
    Toshima, S., Hasegawa, A., Kurabayashi, M., et al (2000) Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol. 20: 22432247.
  • 2
    Libby, P., Ridker, P. M., Maseri, A. (2002) Inflammation and atherosclerosis. Circulation. 105: 11351143.
  • 3
    Wallenfeldt, K., Fagerberg, B., Wikstrand, J., et al (2004) Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med. 256: 413420.
  • 4
    Ridker, P. M., Rifai, N., Stampfer, M. J., et al (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101: 17671772.
  • 5
    Ridker, P. M., Buring, J. E., Shih, J., et al (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 19621967.
  • 6
    Blankenberg, S., Luc, G., Ducimetiere, P., et al (2003) Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 24532459.
  • 7
    Koenig, W., Sund, M., Frohlich, M., et al (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 99: 237242.
  • 8
    Keaney, J. F., Larson, M. G., Vasan, R. S., et al (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 23: 434439.
  • 9
    Festa, A., D'Agostino, R., Jr, Williams, K., et al (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 25: 14071415.
  • 10
    Hansel, B., Giral, P., Nobecourt, E., et al (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab. 89: 49634971.
  • 11
    Festa, A., D'Agostino, R., Jr, Howard, G., et al (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102: 4247.
  • 12
    Lakka, H. M., Laaksonen, D. E., Lakka, T. A., et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 288: 27092716.
  • 13
    Grundy, S. M., Brewer, H. B., Jr, Cleeman, J. I., et al (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109: 433438.
  • 14
    Mohamed-Ali, V., Pinkney, J. H., Coppack, SW (1998) Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 22: 11451158.
  • 15
    Kern, P. A., Ranganathan, S., Li, C., et al (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 280: E745E751.
  • 16
    Bertin, E., Nguyen, P., Guenounou, M., et al (2000) Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab. 26: 178182.
  • 17
    McLaughlin, T., Abbasi, F., Lamendola, C., et al (2002) Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 106: 29082912.
  • 18
    Lavrovsky, Y., Chatterjee, B., Clark, R. A., et al (2000) Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol. 35: 521532.